Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Banks earnings growth | 0.5% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Do Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée's (EPA:CRAV) Earnings Warrant Your Attention?
May 23Should You Buy Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée (EPA:CRAV) For Its Dividend?
Apr 07Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée's (EPA:CRAV) Stock Price Has Reduced 39% In The Past Year
Feb 13Should Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée (EPA:CRAV) Be Part Of Your Dividend Portfolio?
Dec 22In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2023 | 409 | 86 | -903 | -860 | N/A |
9/30/2023 | 421 | 93 | -1,061 | -1,021 | N/A |
6/30/2023 | 432 | 101 | -1,220 | -1,183 | N/A |
3/31/2023 | 453 | 117 | -680 | -647 | N/A |
12/31/2022 | 473 | 133 | -140 | -111 | N/A |
9/30/2022 | 482 | 143 | 213 | 242 | N/A |
6/30/2022 | 490 | 153 | 566 | 595 | N/A |
3/31/2022 | 465 | 133 | 871 | 899 | N/A |
12/31/2021 | 440 | 113 | 1,175 | 1,204 | N/A |
9/30/2021 | 428 | 105 | 661 | 689 | N/A |
6/30/2021 | 416 | 96 | 147 | 174 | N/A |
3/31/2021 | 390 | 74 | 296 | 324 | N/A |
12/31/2020 | 363 | 53 | 445 | 475 | N/A |
9/30/2020 | 369 | 59 | 1,049 | 1,081 | N/A |
6/30/2020 | 374 | 64 | 1,653 | 1,687 | N/A |
3/31/2020 | 403 | 88 | 1,080 | 1,114 | N/A |
12/31/2019 | 431 | 113 | 507 | 541 | N/A |
9/30/2019 | 430 | 118 | 216 | 250 | N/A |
6/30/2019 | 428 | 124 | -76 | -42 | N/A |
3/31/2019 | 433 | 136 | N/A | N/A | N/A |
12/31/2018 | 420 | 123 | -342 | -310 | N/A |
9/30/2018 | 402 | 105 | N/A | N/A | N/A |
6/30/2018 | 401 | 104 | 237 | 264 | N/A |
3/31/2018 | 399 | 102 | N/A | N/A | N/A |
12/31/2017 | 400 | 108 | 320 | 340 | N/A |
9/30/2017 | 400 | 104 | N/A | N/A | N/A |
6/30/2017 | 397 | 102 | N/A | 518 | N/A |
3/31/2017 | 423 | 123 | N/A | N/A | N/A |
12/31/2016 | 411 | 114 | N/A | 737 | N/A |
9/30/2016 | 442 | 141 | N/A | N/A | N/A |
6/30/2016 | 458 | 149 | N/A | 326 | N/A |
3/31/2016 | 424 | 117 | N/A | N/A | N/A |
12/31/2015 | 443 | 131 | N/A | 76 | N/A |
9/30/2015 | 425 | 122 | N/A | -41 | N/A |
6/30/2015 | 408 | 114 | N/A | -158 | N/A |
3/31/2015 | 408 | 116 | N/A | -66 | N/A |
12/31/2014 | 408 | 119 | N/A | 25 | N/A |
9/30/2014 | 436 | 134 | N/A | 34 | N/A |
6/30/2014 | 464 | 148 | N/A | 43 | N/A |
3/31/2014 | 449 | 137 | N/A | 6 | N/A |
12/31/2013 | 435 | 126 | N/A | -30 | N/A |
9/30/2013 | 416 | 111 | N/A | 64 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if CRAV's forecast earnings growth is above the savings rate (1.1%).
Earnings vs Market: Insufficient data to determine if CRAV's earnings are forecast to grow faster than the French market
High Growth Earnings: Insufficient data to determine if CRAV's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if CRAV's revenue is forecast to grow faster than the French market.
High Growth Revenue: Insufficient data to determine if CRAV's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CRAV's Return on Equity is forecast to be high in 3 years time